NCT04614272 is a NA clinical trial of Prayer in Healthy Subjects, sponsored by Antonine University.

Who is sponsoring NCT04614272?

NCT04614272 is sponsored by Antonine University.

What drugs are being tested in NCT04614272?

Interventions in NCT04614272: Prayer, Reading a poem.

What condition does NCT04614272 study?

NCT04614272 studies Healthy Subjects.

Is NCT04614272 still recruiting?

NCT04614272 is currently completed. Last updated 5 September 2021.

Last reviewed 2021-09-05 · How we verify

NCT04614272

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Prayer on Conditioned Pain Modulation and on Pain Intensity in Healthy Religious University Students

Completed NA Last updated 5 September 2021

What this trial tests

NA trial testing Prayer in Healthy Subjects in 208 participants. Completed in 1 February 2021.

Timeline

1 November 2020

Primary endpoint
1 February 2021

1 February 2021

Quick facts

Lead sponsor	Antonine University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	screening
Enrollment	208
Start date	1 November 2020
Primary completion	1 February 2021
Estimated completion	1 February 2021
Sites	1 location across Lebanon

Drugs / interventions tested

Prayer
Reading a poem

Conditions studied

Healthy Subjects — all drugs for Healthy Subjects →

Sponsor

Antonine University

Who can join

Adults 18 to 25, any sex, with Healthy Subjects. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

With this study the investigators wish to examine the effect of prayer on pain intensity and on the conditioned pain modulation in healthy religious university students.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The Effect of Praying on Endogenous Pain Modulation and Pain Intensity in Healthy Religious Individuals in Lebanon: A Randomized Controlled Trial.
Najem C, Meeus M, Cagnie B, Ayoubi F, et al · · 2023 · cited 5× · PMID 36495356 · DOI 10.1007/s10943-022-01714-2

Verify or expand the search:

Other trials of Prayer

Trials testing the same drug.

NCT03356691 — The Evaluation Complementary Spirit Therapy · NA · unknown

Other recruiting trials for Healthy Subjects

Currently open trials in the same condition.

NCT07222020 — Phase 1 Study of Intravaginal KB15A · Phase 1 · recruiting
NCT07350538 — The Critical Link Between Gut Microbiome Dysfunction, Cravings and Relapse: RECLAIM-GUT TRIAL · NA · active not recruiting
NCT07304791 — This is a Phase 1, Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Pharmacokinetics (PK), and P · Phase 1 · recruiting
NCT07059858 — Bladder and Bowel Functions, Participation and Quality of Life in Children With Intellectual Disabilities · recruiting
NCT07331389 — A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04614272 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Antonine University
Last refreshed: 5 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04614272.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing